Derek:talks more about issues e.g. manufacturing, rather than a...

Derek:

• talks more about issues e.g. manufacturing, rather than a clear path to resolution (or immediate solutions)
• repeated "low sales, very very low sales" on EuGeni almost like he was downramping (and not CEO)
• defensive about TGA mistakes and later on acknowledged that he and the team made mistakes and have many learnings. Own it Derek, you have dropped the ball with TGA approvals
• sepsis is a long way off by the sounds of this webinar (look fwd to replaying the recording)
• flu a/b multiplex - so many missed goalposts there
• batteries need to get to 800 cycles (ideally 1000). This too many be some time before we see sales
• one positive is that at least Derek answered the questions, and now we have a factual update from the CEO on record so we all know where we stand

I have been saying for 18 months "can they commercialise and scale". The answer is still no. New leadership required IMO.

For transparency I took some off of the table this morning at 18c to hedge against this webinar. Annoyingly, I was right.

Moose